Shanghai MicroPort MedBot (Group) Company Description

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China.

The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR’obot, a Mona Lisa robotic transperineal prostate biopsy system.

It also offers spine surgical robots for spine surgery; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery.

In addition, it manufactures parts of surgical robot devices; engages in assembly and distribution of surgical robot devices; research and development of system, as well as investment activities.

Shanghai MicroPort MedBot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. The company operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.

Shanghai MicroPort MedBot (Group) Co., Ltd.

Country	China
Founded	2014
Industry	Medical Devices
Sector	Healthcare
Employees	646
CEO	Chao He

Contact Details

Address: Building 1 Shanghai China
Phone	86 21 3895 4600
Website	medbotsurgical.com

Stock Details

Ticker Symbol	2252
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100004QP1
SIC Code	3845

Key Executives

Name	Position
Dr. Chao He	President and Executive Director
Xiaoyu Cui	Financial Controller
Yu Liu	Vice President and Chief Commercial Officer
Cong Fang	Executive Director and Board Secretary